![]() |
Abeitsgruppe Prof. Dr. med. A. zur Hausen
Das Team:
| Axel zur Hausen | Prof. Dr. med. | 0031-43-3874634 |
Department of Pathology Maastricht University Medical Center P.Debylaan 25 Postbus 5800 6202 AZ Maastricht |
| Jasmin Boas | Med. Doktorandin | ||
| Ahmad Kassem | Dr. med./Stipendiat | ||
| Gian Kayser | Dr. med. | 0761 270-80600 (8060 Piepser) |
|
| Marie Löning | Med. Doktorandin | ||
| Henrik Majer | Med. Doktorand | ||
| Deepa Naga Pantulu | Dipl. Biologin | ||
| Anna Verena Pfister | Assistenzärztin | 0761 270-81190 (8131 Piepser) |
Projekte
Molekulare Karzinogenese
Karzinogenese des Magens:
- Am Modell des Epstein-Barr Virus assoziierten Magenkarzinoms gefördert durch das „Joint Transnational Research Programme on Cancer“; Deutscher Akademischer Austauschdienst (DAAD).
- Kooperationsprojekte mit der Chirurgischen Universitätsklinik, Institut für Pathologie Karlsruhe und der Université Lyon, Frankreich.
Karzinogenese gynäkologischer Tumore:
- Prognostische und prädiktive Marker des Mamma- (u.a. chipbasierter Nachweis (ATR reader) in Kooperation mit der Universitätsfrauenklinik, Klinische Chemie und IMTEK; DFG gefördert), Ovarial- und Endometriumkarzinoms
- Kooperationsprojekte mit der Universitätsfrauenklinik.
- Chipbasierter Nachweis humaner Papillomviren in Kooperation mit der Universitätsfrauenklinik, Klinische Chemie und IMTEK
Karzinogenese der Haut:
- Rolle des humanen Merkelzell-Polyoma Virus (MCPyV) in der Karzinogenese humaner Merkelzellkarzinome in Kooperation mit der Universitätshautklinik Freiburg und dem Zentrum für Dermatopathologie Freiburg.
- Rolle des MCPyV in der Pathogenese nicht melanozytärer Hauttumore immunsupprimierter Patienten in Kooperation mit der Universitätshautklinik Freiburg und dem Zentrum für Dermatopathologie Freiburg.
Tumor- und Stromawechselwirkungen
- Bedeutung der Transketolasen als Progressionsmarker (Kolon-, Urothel-, Mamma-, Lungen-, und Larynxkarzinom, Glioblastom) „Warburg Effekt“
- Identifizierung Transketolasen Expression-regulierender Stromafaktoren
- Rolle der Transketolasen in der Immortalisierung und Transformation
Methodisches Spektrum: u.a. DNA/RNA-PCR, Realtime-PCR, SNP-Analysen, Microarray Analysen unterschiedlicher Plattformen (Affymterix und ATR) einschließlich aCGH, Expression- und Spleißarrays. Auf der Seite der Gewebeanalytik verwenden wir Gewebe- und Zellkulturarrays in Kombination mit den unterschiedlichsten Möglichkeiten der in situ Hybridisierungen (FISH, DISH, RISH und CISH). Diese werden komplementiert durch Proteinanalytik, z.B. Immunhistochemie und Western-Blotting.
Publikationen 2006 - 2010
2010
Pantulu ND, Pallasch CP, Kurz AK, Kassem A, Frenzel L, Sodenkamp S, Kvasnicka H, Wendtner CM, zur Hausen A. Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cells. Blood 2010; prepublished online September 3, 2010;DOI 10.1182
Riehle U, Mader A, Brandstetter T, Rühe J, zur Hausen A, Stickeler E. Validation of NASBA in formalin-fixed and paraffin-embedded (FFPE) breast cancer tissues. J Clin Pathol 2010; in press.
Marjanovic G, Schricker M, Walch A, zur Hausen A, Hopt UT, Imdahl A, Makowiec F. Detection of lymph node involvement by cytokeratin immunohistochemistry is an independent prognostic factor after curative resection of esophageal cancer. J Gastrointest Surg 2010; in press
Geddert H, zur Hausen A, Gabbert HE, Sarbia M. EBV-infection in cardiac and non-cardiac gastric carcinoma is associated with promoter methylation of p16, p14 and APC, but not hMLH1. Cell Oncol 2010, in press.
Kassem A, Pantulu ND, Technau K, Kurz AK, Diaz C, Hörster S, Nashan D, Weyers W, zur Hausen A. Merkelcell Polyomavirus in naevoid basal cell carcinoma syndrome- associated basal cell carcinomas and sporadic trichoblastomas. J Dermatol Sci 2010, 59:140-142.
Ouyang YQ, zur Hausen A, Orlowska-Volk M, Jäger M, Bettendorf H, Hirschfeld M, Tong XW, Elmar Stickeler. Expression levels of hnRNP G and hTra2-beta1 have opposite effects on endometrial cancer biology. Int J Cancer, 2010 Jul 6. [Epub ahead of print.].
Mader A, Riehle U, Brandstetter T, Stickeler E, zur Hausen A, Rühe J. Microarray-based amplification and detection of RNA by Nucleic Acid Sequence-Based Amplification (NASBA). Anal Bioanal Chem 2010; 397:3533-3541.
Makowiec F, Möhrle S, Neeff H, Drognitz O, Illerhaus G, Opitz OG, Hopt UT, zur Hausen A. Chemotherapy, liver injury and postoperative complications in colorectal liver metastases. Journal of Gastrointestinal Surgery, in press.
Zhang B, zur Hausen A, Orlowska-Volk M, Jäger M, Bettendorf H, Stamm S, Hirschfeld M, Tong X, Stickeler E. Alternative splicing related factor YT521: an independent prognostic factor in endometrial cancer. Int J Gynecol Cancer 2010; 20:492-499.
Kayser G, Kassem A, Sienel W, Schulte-Uentrop L, Mattern D, Aumann K, Stickeler E, Werner M, Passlick B, zur Hausen A. Lactate-Dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1. Diagn Pathol 2010; 5:22.
Neumann J, Feuerhake F, Kayser G, Wiech T, Passlick B, Fisch P, Werner M, zur Hausen A. Gene expression profiles of lung adenocarcinoma linked to histopathological grading and survival but not to EGF-R status: a microarray study. BMC Cancer 2010; 10:77-88.
Gudlagsson E, Guo LH, Skaland I, Janssen E, van Diest PJ, Voorhorst FJ, Kjellevold K, zur Hausen A, Baak JP. Prospective multicenter comparison of proliferation and other prognostic factors in invasive lobular and ductal breast cancer. Breast Cancer Res Treat 2010; 121:35-40.
Koeberlein B, zur Hausen A, Bektas N, Zentgraf H, Chin R, Toan N, Kandolf R, Torresi J, Bock T. Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver. Virus Res 2010;148:51-59.
Marjanovic G, Villain C, Timme S, zur Hausen A, Hoeppner J, Makowiec F, Holzner P, Hopt UT, Obermaier R. Colloid versus crystalloid infusions in gastrointestinal surgery and their different impact on the healing of intestinal anastomoses. Int J Colorectal Dis 2010;25:491-498.
Brandstetter T, Böhmer S, Prucker O, Wieland H, zur Hausen A, Alt-Mörbe J, Rühe J. Human papilloma virus typing using a new all plastic DNA biochip platform. J Virol Meth 2010;163:40-48.
2009
zur Hausen A. Merkel cell polyomavirus in the pathogenesis of non-melanoma skin cancer. Pathologe 2009 Suppl 2:217-20.
Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A, Brunton VG, Morton J, Sansom O, Schüler J, Stemmler MP, Herzberger C, Hopt U, Keck T, Brabletz S, Brabletz T. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 2009; 11:1487-95.
Gabriel B, Hasenburg A, Waizenegger M, Orlowska-Volk M, Stickeler E, zur Hausen A Expression of Focal Adhesion Kinase (FAK) in Patients with Endometrial Cancer: A Clinico- pathologic Study. Int J Gynecol Cancer 2009; 19:1221-25.
Kassem A, Technau K, Kurz AK, Pantulu D, Löning M, Kayser G, Stickeler E, Weyers W, Diaz C, Werner M, Nashan D, zur Hausen A. Merkel cell polyomavirus sequences are frequently detected in non melanoma skin cancer of immunosuppressed patients. Int J Cancer 2009;125:356-61.
Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F. The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic Cancer. J Gastrointest Surg 2009; 13:1337-44.
Marjanovic G, Jüttner E, Zur Hausen A, Theodor Hopt U, Obermaier R. Ischemic preconditioning improves stability of intestinal anastomoses in rats. Int J Colorectal Dis. 2009; 24:975-81.
Schenk T, Brandstetter T, Zur Hausen A, Alt-Mörbe J, Huzly D, Rühe J. Performance of a polymer-based DNA chip platform in detection and genotyping of human papillomavirus in clinical samples. J Clin Microbiol. 2009; 47:1428-35.
Hirschfeld M, zur Hausen A, Bettendorf H, Jaeger M, Stickeler E. Alternative splicing of Cyr61 is regulated by hypoxia and significantly changed in breast cancer. Cancer Res. 2009; 69:2082-90.
Marjanovic G, Villain C, Juettner E, zur Hausen A, Hoeppner J, Hopt UT, Drognitz O, Obermaier R. Impact of different crystalloid volume regimes on intestinal anastomotic stability. Ann Surg 2009;249:181-5.
Kühnemund A, Liebisch P, Bauchmüller K, zur Hausen A, Veelken H, Wäsch R, Engelhardt M. 'Light-chain escape-multiple myeloma'-an escape phenomenon from plateau phase: report of the largest patient series using LC-monitoring. J Cancer Res Clin Oncol 2009;135:477-84.
Baak JPA, Gudlaugsson E, Skaland I, Guo LHR, , Klos J, Lende TH, Søiland H, Janssen EAM, zur Hausen A (2008). Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers. Breast Cancer Res Treat 2009;115:241-54.
Gabriel B, zur Hausen A, Bouda J, Boudova L, Koprivova M, Hirschfeld M, Jäger M, Stickeler E. Significance of nuclear hTra2-beta1 expression in cervical cancer. Acta Obstet Gynecol Scand 2009; 88:216-21.
Xu X, zur Hausen A, Coy JF, Löchelt M. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells. Int J Cancer 2009; 124:1330-7.
2008
Kassem A, Schöpflin A, Diaz C, Weyers W, Stickeler E, Werner M, Zur Hausen A. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res 2008;68:5009-13.
Wiech T, Nikolopoulos E, Lassman S, Heidt T, Schöpflin A, Sarbia M, Werner M, Shimizu Y, Sakka E, Ooka T, zur Hausen A. Cyclin D1 expression is induced by viral BARF1 and is overexpressed in EBV-associated gastric cancer. Virchows Arch 2008; 452:621-7.
Mayer S, zur Hausen A, Watermann DO, Jäger M, Fischer DC, Gitsch G, Stickeler E. Increased soluble CD44 concentrations are asssociated with larger tumor size and lymph node metastasis in breast cancer patients. J Cancer Res Clin Oncol 2008; 134:1229-35.
Langbein S, Frederiks WM, zur Hausen A, Popa J, Lehmann J, Weiss C, Alken P, Coy JF. Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer. Int J Cancer 2008;122:2422-8.
2007
Földi M, Stickeler E, Bau L, Kretz O, Watermann D, Gitsch G, Kayser G, zur Hausen A, Coy JF. Transketolase protein TKTL1 overexpression: a potential biomarker and therapeutic target in breast cancer. Oncol Rep 2007; 4:841-5.
Lassmann S, Tang L, Capanu M, Schöpflin A, zur Hausen A, Gonen M, Kemeny N, Shia JR, Klimstrda D, Werner M. A novel prognostic and predictive molecular marker panel for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy. Gastroenterology 2007;133:1831–9.
2006
Lazar F, zur Hausen A, Mischkowski R, Zoller JE. Atypical cyst formation following chin augmentation using a nasal osteocartilaginous graft. J Craniomaxillofac Surg 2006; 34:107-112.
Gabriel B, Watermann DO, Hancke K, Gitsch G, Werner M, Tempfer C, zur Hausen A. Immunohistochemical expression of matrix metalloproteinases 1 and 2 in uterosacral ligaments in women with or without pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:478-482.
van Beek J, zur Hausen A, Snel SN, Berkhof J, Klein Kranenbarg E, van de Velde CJH, van den Brule AJC, Middeldorp JM, Meijer CJLM, Bloemena E (2006). Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases. Am J Surg Pathol 2006;30:59-65.
Knoess M, Kurz AK, Goreva O, Bektas N, Breuhahn K, Odenthal M, Schirmacher P, Dienes HP, Bock CT, Zentgraf H, zur Hausen A. Nup88 expression in Hepatitis B and C virus related diseases of the liver. World J Gastroenterol 2006;12:5870-74.
Gabriel B, Fischer DC, Orlowska-Volk M, zur Hausen A, Schüle R, Müller JM, Hasenburg A. Expression of the Transcriptional co-Regulator FHL2 in Human Breast Cancer: A clinico-pathologic Study. J Soc Gyn Invest 2006;13:69-75.
Langbein S, Zerilli M, zur Hausen A, Staiger W, Dressler D, Rensch-Boschert K, Lukan N, Popa J, Ternullo M, Steidler A, Weiss C, Michel MS, Grobholz R, Willeke F, Alken P, Stassi G, Schubert P, Coy JF. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br J Cancer 2006;94: 578-85.
Drebber U, Haferkamp K, Kern MA, Müller M, zur Hausen A, Kasper HU, Odenthal M, Dienes HP (2006). Induction of early murine Cytomegalovirus Infection by different reporter-gene associated recombinant viruses. J Viral Hepatitis 2006;13:363-70.
Drebber U, Kasper HU, Krupacz J, Haferkamp K, Kern MA, Steffen HM, Quasdorff M, zur Hausen A, Odenthal M, Dienes HP. The role of Epstein-Barr Virus in acute and chronic hepatitis. J Hepatol 2006;44:879-85.
Gabriel B, zur Hausen A, Stickeler E, Dietz C, Gitsch G, Fischer DC, Bouda J, Tempfer C, Hasenburg A. Decreased expression of focal adhesion kinase (pp125FAK) in patients with cervical cancer is associated with poor disease outcome. Clin Cancer Res 2006;12:2476-83.
Watermann DO, Tang Y, zur Hausen A, Jäger M, Stamm S, Stickeler S. Splicing factor TRA2ß1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene. Cancer Res 2006;66:4774-80.
(p)














